Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2001-2010 of 2400 for

Edit search filters
  1. REFINE: Regorafenib Observational Study In Hepatocellular Carcinoma

    Rochester, MN

  2. A Study to Evaluate Immunotherapy and Ovarian Function Among Pre-menopausal Melanoma Survivors

    Rochester, MN

  3. Pancreatic Cancer Detection Consortium

    Rochester, MN

  4. A Single Patient Study Of Severe Fibrosis After Breast Radiation

    Rochester, MN

  5. Evaluating Surgical Treatment Related Differences In Patient Satisfaction And Health-related Quality Of Life In Breast Cancer Survivors In The Long-term Survivorship Period

    Rochester, MN

  6. A Study To Better Understand How To Predict And Manage Patients Who Are At High Risk For Developing Rheumatic Immune-related Adverse Events While Receiving Treatment For Melanoma

    Rochester, MN

  7. Study Using Chromogranin A As Surveillance Biomarker In Patients With CARcinoids

    Rochester, MN

  8. A Study Of Quality Of Life After Thyroid Cancer Surgery

    Scottsdale/Phoenix, AZ

  9. A Study to Evaluate Artificial Intelligence-driven Assistance for Treatment Planning in Radiation Oncology

    Rochester, MN

  10. Ado-trastuzumab emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

    Rochester, MN

.

Mayo Clinic Footer